DID YOU KNOW? DTIC has over 3.5 million final reports on DoD funded research, development, test, and evaluation activities available to our registered users. Click
HERE to register or log in.
Accession Number:
ADA616972
Title:
Targeting Common but Complex Proteoglycans on Breast Cancer Cells and Stem Cells Using Evolutionary Refined Malaria Proteins
Descriptive Note:
Annual rept. 15 Aug 2013-14 Aug 2014
Corporate Author:
COPENHAGEN UNIV (DENMARK)
Report Date:
2014-09-01
Pagination or Media Count:
16.0
Abstract:
In the past year of the project we have successfully produced recombinant VAR2CSA that binds with high affinity and high specificity to breast cancer cells and breast cancer tissue biopsies. We have demonstrated that the protein binds to distinct secondary modified proteoglycans exclusively present on breast cancer cells and that targeting these with recombinant VAR2CSA interferes with key functions of the cancer cell like growth, migration and invasion.
Distribution Statement:
APPROVED FOR PUBLIC RELEASE